| WKN: | A1JP9Y |
| ISIN: | DK0060336014 |
| Land: | Dänemark |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Biotechnologie |
Weshalb die Novonesis-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 27. Oktober 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2021 | 47,11 | 72,54 | 53,98% |
| 2 | 2010 | 14,39 | 21,00 | 45,89% |
| 3 | 2013 | 21,25 | 30,88 | 45,29% |
| 4 | 2017 | 32,95 | 47,33 | 43,63% |
| 5 | 2006 | 9,13 | 12,95 | 41,76% |
| 6 | 2003 | 4,00 | 5,44 | 35,90% |
| 7 | 2004 | 5,44 | 7,37 | 35,65% |
| 8 | 2009 | 10,94 | 14,39 | 31,60% |
| 9 | 2015 | 35,11 | 44,47 | 26,68% |
| 10 | 2005 | 7,37 | 9,13 | 23,87% |
| 11 | 2007 | 12,95 | 15,40 | 18,95% |
| 12 | 2019 | 38,55 | 43,93 | 13,96% |
| 13 | 2014 | 30,88 | 35,11 | 13,69% |
| 14 | 2011 | 21,00 | 23,63 | 12,53% |
| 15 | 2001 | 4,10 | 4,50 | 9,76% |
| 16 | 2024 | 50,02 | 54,54 | 9,04% |
| 17 | 2020 | 43,93 | 47,11 | 7,24% |
| 18 | 2023 | 47,22 | 50,02 | 5,93% |
| 19 | 2025 | 54,54 | 54,42 | -0,22% |
| 20 | 2012 | 23,63 | 21,25 | -10,06% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2022 | 72,54 | 47,22 | -34,90% |
| 2 | 2008 | 15,40 | 10,94 | -28,98% |
| 3 | 2016 | 44,47 | 32,95 | -25,91% |
| 4 | 2018 | 47,33 | 38,55 | -18,55% |
| 5 | 2002 | 4,50 | 4,00 | -11,11% |
| 6 | 2012 | 23,63 | 21,25 | -10,06% |
| 7 | 2025 | 54,54 | 54,42 | -0,22% |
| 8 | 2023 | 47,22 | 50,02 | 5,93% |
| 9 | 2020 | 43,93 | 47,11 | 7,24% |
| 10 | 2024 | 50,02 | 54,54 | 9,04% |
| 11 | 2001 | 4,10 | 4,50 | 9,76% |
| 12 | 2011 | 21,00 | 23,63 | 12,53% |
| 13 | 2014 | 30,88 | 35,11 | 13,69% |
| 14 | 2019 | 38,55 | 43,93 | 13,96% |
| 15 | 2007 | 12,95 | 15,40 | 18,95% |
| 16 | 2005 | 7,37 | 9,13 | 23,87% |
| 17 | 2015 | 35,11 | 44,47 | 26,68% |
| 18 | 2009 | 10,94 | 14,39 | 31,60% |
| 19 | 2004 | 5,44 | 7,37 | 35,65% |
| 20 | 2003 | 4,00 | 5,44 | 35,90% |